Sanjay Asthana

ADRC Director


Dr. Asthana is interested in clinical psychopharmacology and neuroendocrinology of gonadal steroids and cholinergic drugs in Alzheimer’s disease and healthy aging

  1. Cognitive and neuroendocrine effects of estrogen and testosterone administration in Alzheimer’s disease and healthy aging.
  2. Potential beneficial effects of estrogen and testosterone treatment on performance-based measures of independent living skills for healthy older adults as well as those with Alzheimer’s disease.
  3. Identification of biological markers for therapeutic responsivity to estrogen for women with Alzheimer’s disease.
  4. Evaluation of therapeutic efficacy of raloxifene, a selective estrogen receptor modulator (SERM), in subjects with Alzheimer’s disease.
  5. Cholinergic drugs: Clinical psychopharmacology studies in Alzheimer’s disease.
  6. Clinical pharmacokinetics and neuroendocrinology of cholinergic drugs in subjects with AD.